Low Dose Aspirin Alerts in High-Risk Pregnancies
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT Number: NCT00456118
Justification:
We have recently demonstrated that maternofetal alloimmunization was not limited to blood cells: maternal alloimmunization against a glomerular podocyte antigen expressed by the placenta can induce neonatal membranous glomerulonephritis.
Early recurrent pregnancy losses, preeclampsia and intervillositis are obstetrical pathologies which share an anomaly of placentation. Pathophysiology of these diseases is not yet fully understood; nevertheless the hypothesis of an incompatibility between mother and child is often mentioned. The aim of this project is to detect and study the cases of recurrent pregnancy losses, preeclamspia and intervillositis which could be induced by tissular maternofetal alloimmunization.
Materials and methods:
Patients suffering from recurrent pregnancy losses of unknown origin, preeclamspia or intervillositis will be included in this project. Mothers' sera will be studied by indirect immunofluorescence and Western Blot on placental biopsies from different origins and gestational ages. This stage will enable us to detect possible maternal allo-antibodies. After detecting and revealing antibodies, nature of the target antigen will be identified by immunoprecipitation of placental extracts, using the positive sera. Immunoprecipitation will be followed by a mass spectrometry analysis of detected proteins.
Expected results:
This study will enable us:
* to detect new cases of tissular maternofetal alloimmunization * to improve our knowledge of mechanisms leading to anomalies of placentation * to carry out a specific, preventive therapeutic approach for cases induced by tissular alloimmunization.
Key words:
Recurrent pregnancy losses, Preeclampsia, Intervillositis, maternofetal alloimmunization.
Looking for future studies?
Notify Me18 year–45 year
Female
Observational
Bordeaux University Hospital, Bordeaux, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Hospital, Limoges
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07265336
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Panama City, Provincia de Panamá, Panama
View Trial DetailsNCT07040696
Acute Kidney Injury, Female Urogenital Diseases
Cairo, Giza Governorate, Egypt
View Trial Details